Jan 4, 2017
Analyst Activity – JMP Securities Initiates Coverage On Madrigal Pharmaceuticals (NASDAQ:MDGL) With a Outperform
Analyst Activity – JMP Securities Initiates Coverage On Madrigal Pharmaceuticals (NASDAQ:MDGL) With a Outperform
Analyst Ratings For Madrigal Pharmaceuticals (NASDAQ:MDGL) Today, JMP Securities initiated coverage on Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Outperform. There are 1 buy rating on the stock. The current consensus rating on Madrigal Pharmaceuticals (NASDAQ:MDGL) is Buy (Score: 3.00) with a consensus target price of per share, a potential . Some recent analyst ratings include 1/3/2017-JMP…
View On WordPress